172 related articles for article (PubMed ID: 23320731)
1. Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort.
Goh CL; Saunders EJ; Leongamornlert DA; Tymrakiewicz M; Thomas K; Selvadurai ED; Woode-Amissah R; Dadaev T; Mahmud N; Castro E; Olmos D; Guy M; Govindasami K; O'Brien LT; Hall AL; Wilkinson RA; Sawyer EJ; Al Olama AA; Easton DF; Kote-Jarai Z; Parker CC; Eeles RA
BJU Int; 2013 Sep; 112(5):666-73. PubMed ID: 23320731
[TBL] [Abstract][Full Text] [Related]
2. The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.
Castro E; Mikropoulos C; Bancroft EK; Dadaev T; Goh C; Taylor N; Saunders E; Borley N; Keating D; Page EC; Saya S; Hazell S; Livni N; deSouza N; Neal D; Hamdy FC; Kumar P; Antoniou AC; Kote-Jarai Z; ; Eeles RA
Oncologist; 2016 Jun; 21(6):716-22. PubMed ID: 27151655
[TBL] [Abstract][Full Text] [Related]
3. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
Fitzgerald LM; Kwon EM; Koopmeiners JS; Salinas CA; Stanford JL; Ostrander EA
Clin Cancer Res; 2009 May; 15(9):3231-7. PubMed ID: 19366831
[TBL] [Abstract][Full Text] [Related]
4. Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.
Na R; Labbate C; Yu H; Shi Z; Fantus RJ; Wang CH; Andriole GL; Isaacs WB; Zheng SL; Helfand BT; Xu J
JAMA Netw Open; 2019 Dec; 2(12):e1918145. PubMed ID: 31880795
[TBL] [Abstract][Full Text] [Related]
5. Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.
Orozco G; Goh CL; Al Olama AA; Benlloch-Garcia S; Govindasami K; Guy M; Muir KR; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Kote-Jarai Z; Easton DF; Eyre S; Eeles RA
BJU Int; 2013 Jun; 111(7):1148-55. PubMed ID: 22985493
[TBL] [Abstract][Full Text] [Related]
6. Genetic predisposition to prostate cancer.
Benafif S; Eeles R
Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
[TBL] [Abstract][Full Text] [Related]
7. Association between metformin medication, genetic variation and prostate cancer risk.
Lee MJ; Jayalath VH; Xu W; Lu L; Freedland SJ; Fleshner NE; Kulkarni GS; Finelli A; van der Kwast TH; Hamilton RJ
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):96-105. PubMed ID: 32424261
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
[TBL] [Abstract][Full Text] [Related]
9. Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.
Chen H; Liu X; Brendler CB; Ankerst DP; Leach RJ; Goodman PJ; Lucia MS; Tangen CM; Wang L; Hsu FC; Sun J; Kader AK; Isaacs WB; Helfand BT; Zheng SL; Thompson IM; Platz EA; Xu J
Prostate; 2016 Sep; 76(12):1120-9. PubMed ID: 27197965
[TBL] [Abstract][Full Text] [Related]
10. Clinical validity and utility of genetic risk scores in prostate cancer.
Helfand BT; Kearns J; Conran C; Xu J
Asian J Androl; 2016; 18(4):509-14. PubMed ID: 27297129
[TBL] [Abstract][Full Text] [Related]
11. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Wang V; Geybels MS; Jordahl KM; Gerke T; Hamid A; Penney KL; Markt SC; Freedman M; Pomerantz M; Lee GM; Rana H; Börnigen D; Rebbeck TR; Huttenhower C; Eeles RA; Stanford JL; Consortium P; Berndt SI; Claessens F; Sørensen KD; Park JY; Vega A; Usmani N; Mucci L; Sweeney CJ
Prostate; 2021 Jul; 81(10):683-693. PubMed ID: 33956343
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility loci associated with prostate cancer progression and mortality.
Gallagher DJ; Vijai J; Cronin AM; Bhatia J; Vickers AJ; Gaudet MM; Fine S; Reuter V; Scher HI; Halldén C; Dutra-Clarke A; Klein RJ; Scardino PT; Eastham JA; Lilja H; Kirchhoff T; Offit K
Clin Cancer Res; 2010 May; 16(10):2819-32. PubMed ID: 20460480
[TBL] [Abstract][Full Text] [Related]
13. A genome-wide pleiotropy scan for prostate cancer risk.
Panagiotou OA; Travis RC; Campa D; Berndt SI; Lindstrom S; Kraft P; Schumacher FR; Siddiq A; Papatheodorou SI; Stanford JL; Albanes D; Virtamo J; Weinstein SJ; Diver WR; Gapstur SM; Stevens VL; Boeing H; Bueno-de-Mesquita HB; Barricarte Gurrea A; Kaaks R; Khaw KT; Krogh V; Overvad K; Riboli E; Trichopoulos D; Giovannucci E; Stampfer M; Haiman C; Henderson B; Le Marchand L; Gaziano JM; Hunter DJ; Koutros S; Yeager M; Hoover RN; ; Chanock SJ; Wacholder S; Key TJ; Tsilidis KK
Eur Urol; 2015 Apr; 67(4):649-57. PubMed ID: 25277271
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.
Teerlink CC; Leongamornlert D; Dadaev T; Thomas A; Farnham J; Stephenson RA; Riska S; McDonnell SK; Schaid DJ; Catalona WJ; Zheng SL; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Giles GG; Southey MC; Fitzgerald LM; Rinckleb A; Luedeke M; Maier C; Stanford JL; Ostrander EA; Kaikkonen EM; Sipeky C; Tammela T; Schleutker J; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Xu J; Cancel-Tassin G; Cussenot O; Mandal D; Laurie C; Laurie C; ; ; Thibodeau SN; Eeles RA; Kote-Jarai Z; Cannon-Albright L
Hum Genet; 2016 Aug; 135(8):923-38. PubMed ID: 27262462
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
Ishak MB; Giri VN
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
[TBL] [Abstract][Full Text] [Related]
16. Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.
Ren S; Xu J; Zhou T; Jiang H; Chen H; Liu F; Na R; Zhang L; Wu Y; Sun J; Yang B; Gao X; Zheng SL; Xu C; Ding Q; Sun Y
Prostate; 2013 Dec; 73(16):1824-35. PubMed ID: 24037738
[TBL] [Abstract][Full Text] [Related]
17. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.
Salinas CA; Koopmeiners JS; Kwon EM; FitzGerald L; Lin DW; Ostrander EA; Feng Z; Stanford JL
Prostate; 2009 Mar; 69(4):363-72. PubMed ID: 19058137
[TBL] [Abstract][Full Text] [Related]
19. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.
Conran CA; Na R; Chen H; Jiang D; Lin X; Zheng SL; Brendler CB; Xu J
Asian J Androl; 2016; 18(4):520-4. PubMed ID: 27080480
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.
Ahn J; Kibel AS; Park JY; Rebbeck TR; Rennert H; Stanford JL; Ostrander EA; Chanock S; Wang MH; Mittal RD; Isaacs WB; Platz EA; Hayes RB
Clin Cancer Res; 2011 Mar; 17(5):1075-81. PubMed ID: 21343373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
